Document Detail


Malignant ventricular arrhythmias are well tolerated in patients receiving long-term left ventricular assist devices.
MedLine Citation:
PMID:  7963116     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: We sought to quantitate the incidence of malignant ventricular arrhythmias and to identify subsequent hemodynamic changes and untoward events in patients who have received an implantable left ventricular circulatory assist device as an extended bridge to heart transplantation. BACKGROUND: Implantable long-term mechanical circulatory assist devices have been used clinically with increasing frequency and success for the past 4 years. Previous investigators have suggested that patients with malignant ventricular arrhythmias receiving a left ventricular assist device will require both left and right ventricular assistance to maintain vital organ perfusion. METHODS: We reviewed our 4-year experience with 21 patients who underwent implantation of a left ventricular assist device. Device flows and mean arterial pressure were used to assess systemic perfusion; central venous pressure provided a gauge of right ventricular function. Charts were screened for evidence of end-organ injury resulting from malignant ventricular arrhythmias. RESULTS: Malignant ventricular arrhythmias occurred in 4 patients (19%) before device placement and in 9 patients (43%) during device support. The latter nine patients formed the final study group; their arrhythmias occurred 0 to 186 days after device implantation and had a duration of 10 min to 12 days. The patients reported weakness or palpitation; however, none reported syncope or dyspnea. Mean arterial pressure and central venous pressure were insignificantly changed by the arrhythmias. Device flow decreased by 1.4 +/- 0.6 liters/min (p < 0.05) at the onset of the arrhythmias but returned to normal after cardioversion. No thromboembolic events or significant end-organ dysfunction occurred. CONCLUSION: Absence of right ventricular contraction during malignant ventricular arrhythmias is well tolerated in recipients of a left ventricular assist device. The diagnosis of malignant arrhythmia should be suspected if an unexplained decrease in left ventricular assist device flow occurs. Early electrical cardioversion is warranted to avoid both thrombus formation in the native heart and right ventricular myocardial injury from prolonged fibrillation.
Authors:
M C Oz; E A Rose; J Slater; J J Kuiper; K A Catanese; H R Levin
Related Documents :
12057706 - Successful cardiac transplantation after 4 cases of debakey left ventricular assist dev...
9080176 - Novacor lvad bridge to transplantation in peripartum cardiomyopathy.
11739306 - Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass as...
6616366 - Femorofemoral bypass for temporary cardiac support in heart surgery.
9056616 - Bigated transcranial doppler for the detection of clinically silent circulating emboli ...
16810136 - Long-term follow-up of mitral valve repair: a single-center experience.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American College of Cardiology     Volume:  24     ISSN:  0735-1097     ISO Abbreviation:  J. Am. Coll. Cardiol.     Publication Date:  1994 Dec 
Date Detail:
Created Date:  1994-12-16     Completed Date:  1994-12-16     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  8301365     Medline TA:  J Am Coll Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1688-91     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiac Surgery, College of Physicians and Surgeons, Columbia University, New York, New York.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Cardiomyopathy, Dilated / physiopathology,  surgery*
Female
Heart-Assist Devices*
Hemodynamics
Humans
Male
Middle Aged
Postoperative Complications / physiopathology
Stroke Volume
Tachycardia, Ventricular / etiology,  physiopathology*
Treatment Outcome
Ventricular Fibrillation / etiology,  physiopathology*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables...
Next Document:  Lessons learned from data logging in a multicenter clinical trial using a late-generation implantabl...